ICON has opened a purpose-built clinical pharmacology unit in the Central Manchester University Hospitals Foundation Trust (CMFT) campus in Manchester, UK. In June the company began initial studies at the unit using translational medicine methodologies to expedite drug development projects. The 34-bed hospital-based unit brings ICON’s Phase I global bed capacity to more than 280 beds, and includes a sample handling lab, 24-hour medical cover, local GMP pharmacy, access to the Accident and Eme...